| Literature DB >> 32791715 |
Yongliang Jiang1, Hantong Hu1,2, Xiaoyu Li1, Xiaofen He1, Xiaomei Shao1, Jiali Lou1, Yajun Zhang1, Yuanyuan Wu1,2, Jianqiao Fang1.
Abstract
INTRODUCTION: By detecting the metabolic difference of the Heart and Lung meridians, the present study aims to investigate the specificity of different meridians and verify whether functional near infrared spectroscopy is validated as an add-on technique to assist diagnosis of chronic obstructive pulmonary disease (COPD). METHODS AND ANALYSIS: The Lung and Heart meridians are chosen as the target for comparison; accordingly, 120 eligible participants will be included and divided into the COPD group, healthy control group, and healthy intervention group. Functional near infrared spectroscopy will be adopted to measure the metabolic characteristics of the Heart and Lung meridians. On one hand, the specificity of the meridian-visceral association will be investigated by comparing the metabolic difference in the Heart and Lung meridians between the healthy control group and COPD group. On the other hand, the specificity of site-to-site association will be determined by comparing the metabolic change between the 2 meridians that induced by moxibustion in the Heart meridian and Lung meridian, respectively, in the healthy control group. The primary outcome will be regional oxygen saturation of corresponding regions along the Heart and Lung meridians. TRIAL REGISTRATION: ClinicalTrials.gov NCT04046666.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32791715 PMCID: PMC7386978 DOI: 10.1097/MD.0000000000021302
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Figure 1Study design flowchart. COPD = chronic obstructive pulmonary disease, fNIRS = functional near infrared spectroscopy, rSO2 = regional oxygen saturation.
Trial schedule for enrollment, intervention, and assessments.
Figure 2The fNIRS measurement sites of the COPD group and healthy control group. COPD = chronic obstructive pulmonary disease, fNIRS = functional near infrared spectroscopy.
Figure 3The intervention procedure of the healthy intervention group. (A) Moxibustion site of the Heart meridian and the fNIRS measurement sites of the Heart and Lung meridians; (B) Moxibustion site of the Lung meridian and the fNIRS measurement sites of the Heart and Lung meridians. fNIRS = functional near infrared spectroscopy.